SPP1 and lung adenocarcinoma: In summary, this study identified eCAFs closely associated with poor prognosis in lung adenocarcinoma, characterized eCAFs' role in ECM remodeling via extracellular matrix proteins, and explored the interactions between eCAFs and SPP1+ macrophages, including potential ligand-receptor pairs which provided potential targets for targeting eCAFs therapy.